Rajarajan Amirthalingam Thandavarayan

Dr. Rajarajan Amirthalingam Thandavarayan

Houston Methodist Hospital
+1
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VGVijayasree Giridharan
Vijayasree Giridharan
Rajarajan Amirthalingam ThandavarayanRajarajan Amirthalingam Thandavarayan
Rajarajan Amirthalingam Thandavarayan
SASomasundaram Arumugam
Somasundaram Arumugam
MMMakoto Mizuno
Makoto Mizuno
HNHiroyuki Nawa
Hiroyuki Nawa
TKTetsuya Konishi
Tetsuya Konishi
Amyloid β (Aβ)-induced neurotoxicity is a major pathological mechanism of Alzheimer’s disease (AD). Our previous studies have demonstrated that schisandrin B (Sch B), an antioxidant lignan from Schisandra chinensis, could protect mouse brain against scopolamine- and cisplatin-induced neuronal dysfunction. In the present study, we examined the protective effect of Sch B against intracerebroventricular (ICV)-infused Aβ-induced neuronal dysfunction in rat cortex and explored the potential mechanism of its action. Our results showed that 26 days co-administration of Sch B significantly improved the behavioral performance of Aβ (1–40)-infused rats in step-through test. At the same time, Sch B attenuated Aβ-induced increases in oxidative and nitrosative stresses, inflammatory markers such as inducible nitric oxide syntheses, cyclooxygenase-2, interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α, and DNA damage. Several proteins such as receptor for advanced glycation end products (RAGE), nuclear factor-κB, mitogen-activated protein kinases, and apoptosis markers were over expressed in Aβ-infused rats but were significantly inhibited by Sch B treatment. Furthermore, Sch B negatively modulated the Aβ level with simultaneous up-regulation of HSP70 and beclin, autophagy markers in Aβ-infused rats. The aforementioned effects of Sch B suggest its protective role against Aβ-induced neurotoxicity through intervention in the negative cycle of RAGE-mediated Aβ accumulation during AD patho-physiology.

1 August 2017 in Drug Discovery Today
Verified
Journal Article
Closed access
Rajendran JC boseRajendran JC bose
Rajendran JC bose
RRRramaswamy Ravikumar
Rramaswamy Ravikumar
VKVengadeshprabu Karuppagounder
Vengadeshprabu Karuppagounder
DBDevasier Bennet
Devasier Bennet
SRSabarinathan Rangasamy
Sabarinathan Rangasamy
Rajarajan Amirthalingam ThandavarayanRajarajan Amirthalingam Thandavarayan
Rajarajan Amirthalingam Thandavarayan

8 April 2019 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
TWTingting Weng
Tingting Weng
JKJunsuk Ko
Junsuk Ko
CMChioniso P. Masamha
Chioniso P. Masamha
ZXZheng Xia
Zheng Xia
YXYu Xiang
Yu Xiang
MBMichael R. Blackburn
Michael R. Blackburn
Idiopathic pulmonary fibrosis (IPF) is a chronic and deadly disease with a poor prognosis and few treatment options. Pathological remodeling of the extracellular matrix (ECM) by myofibroblasts is a key factor that drives disease pathogenesis, although the underlying mechanisms remain unknown. Alternative polyadenylation (APA) has recently been shown to play a major role in cellular responses to stress by driving the expression of fibrotic factors and ECMs through altering microRNA sensitivity, but a connection to IPF has not been established. Here, we demonstrate that CFIm25, a global regulator of APA, is down-regulated in the lungs of patients with IPF and mice with pulmonary fibrosis, with its expression selectively reduced in alpha-smooth muscle actin (α-SMA) positive fibroblasts. Following the knockdown of CFIm25 in normal human lung fibroblasts, we identified 808 genes with shortened 3′UTRs, including those involved in the transforming growth factor-β signaling pathway, the Wnt signaling pathway, and cancer pathways. The expression of key pro-fibrotic factors can be suppressed by CFIm25 overexpression in IPF fibroblasts. Finally, we demonstrate that deletion of CFIm25 in fibroblasts or myofibroblast precursors using either the Col1a1 or the Foxd1 promoter enhances pulmonary fibrosis after bleomycin exposure in mice. Taken together, our results identified CFIm25 down-regulation as a novel mechanism to elevate pro-fibrotic gene expression in pulmonary fibrosis.

12 April 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VKVengadeshprabhu Karuppagounder
Vengadeshprabhu Karuppagounder
VGVijayasree Giridharan
Vijayasree Giridharan
SASomasundaram Arumugam
Somasundaram Arumugam
RSRemya Sreedhar
Remya Sreedhar
SPSuresh S. Palaniyandi
Suresh S. Palaniyandi
Rajarajan Amirthalingam ThandavarayanRajarajan Amirthalingam Thandavarayan
Rajarajan Amirthalingam Thandavarayan
The aim of this study was to investigate the role of macrophage polarization in aging heart. Macrophage differentiation is pathogenically linked to many inflammatory and immune disorders. It is often preceded by myocardial inflammation, which is characterized by increased cardiac damage and pro-inflammatory cytokine levels. Therefore, we investigated the hypothesis that senescence accelerated-prone (SAMP8) mice cardiac tissue would develop macrophage polarization compared with senescence-resistant control (SAMR1) mice. Both SAMP8 and SAMR1 mice were sacrificed when they became six month old. We evaluated, histo-pathological changes and modifications in protein expression by Western blotting and immuno-histochemical staining for M1 and M2 macrophage markers, high mobility group protein (HMG)B1 and its cascade proteins, pro-inflammatory factors and inflammatory cytokines in cardiac tissue. We observed significant upregulation of HMGB1, toll-like receptor (TLR)2, TLR4, nuclear factor (NF)κB p65, tumor necrosis factor (TNF)α, cyclooxygenase (COX)2, interferon (IFN)γ, interleukin (IL)-1β, IL-6 and M1 like macrophage specific marker cluster of differentiation (CD)68 expressions in SAMP8 heart. In contrast, M2 macrophage specific marker CD36, and IL-10 expressions were down-regulated in SAMP8 mice. The results from the study demonstrated that, HMGB1-TLR2/TLR4 signaling cascade and induction of phenotypic switching to M1 macrophage polarization in SAMP8 mice heart would be one of the possible reasons behind the cardiac dysfunction and thus it could become an important therapeutic target to improve the age related cardiac dysfunction.

1 May 2017 in Ageing Research Reviews
Verified
Journal Article
Closed access
VKVengadeshprabhu Karuppagounder
Vengadeshprabhu Karuppagounder
SASomasundaram Arumugam
Somasundaram Arumugam
SBSahana Suresh Babu
Sahana Suresh Babu
SPSuresh S. Palaniyandi
Suresh S. Palaniyandi
KWKenichi Watanabe
Kenichi Watanabe
Rajarajan Amirthalingam ThandavarayanRajarajan Amirthalingam Thandavarayan
Rajarajan Amirthalingam Thandavarayan

Verified
Journal Article
Open access
PDF file
Harry karmouty-QuintanaHarry karmouty-Quintana
Harry karmouty-Quintana
Rajarajan Amirthalingam ThandavarayanRajarajan Amirthalingam Thandavarayan
Rajarajan Amirthalingam Thandavarayan
SKSteven P. Keller
Steven P. Keller
SSSandeep Sahay
Sandeep Sahay
LPLavannya M. Pandit
Lavannya M. Pandit
BABindu Akkanti
Bindu Akkanti
The 1918 influenza killed approximately 50 million people in a few short years, and now, the world is facing another pandemic. In December 2019, a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused an international outbreak of a respiratory illness termed coronavirus disease 2019 (COVID-19) and rapidly spread to cause the worst pandemic since 1918. Recent clinical reports highlight an atypical presentation of acute respiratory distress syndrome (ARDS) in COVID-19 patients characterized by severe hypoxemia, an imbalance of the renin–angiotensin system, an increase in thrombogenic processes, and a cytokine release storm. These processes not only exacerbate lung injury but can also promote pulmonary vascular remodeling and vasoconstriction, which are hallmarks of pulmonary hypertension (PH). PH is a complication of ARDS that has received little attention; thus, we hypothesize that PH in COVID-19-induced ARDS represents an important target for disease amelioration. The mechanisms that can promote PH following SARS-CoV-2 infection are described. In this review article, we outline emerging mechanisms of pulmonary vascular dysfunction and outline potential treatment options that have been clinically tested.